INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Phocas Financial Corp.'s Holding History (CIK: 0001356783)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 30,207 Value ($000) $1,252 Avg Close Range
Q2 2020
Shares 29,217 Value ($000) $1,399 Avg Close Range
Q1 2020
Shares 17,402 Value ($000) $1,095 Avg Close Range
Q4 2019
Shares 18,914 Value ($000) $2,343 Avg Close Range